Thomas Dick

64PUBLICATIONS
59CO-AUTHORS
PharmacogenomicsBiologically active moleculesMedical infection agents (incl. prions)Medical mycologyMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (64)

|Jun 23, 2026
Rifamycin Structural Modifications Attenuate PXR Binding and CYP3A4 Induction.

|Jun 02, 2026
Cytochrome P450-Mediated Metabolism of Antimycobacterial Nα-Aroyl-N-aryl-phenylalanine Amides.

|Jan 28, 2026
Loss-of-Function Mutations in the Penicillin-Binding Protein PonA1 Confer Agar-Dependent Resistance to Durlobactam in Mycobacterium abscessus.

Dereje Abate Negatu, Wassihun Wedajo Aragaw, Min Xie

|May 01, 2025
Next-generation rifamycins for the treatment of mycobacterial infections.

Véronique Dartois, Tian Lan, Uday S Ganapathy

|Apr 01, 2025
Toward a Bactericidal Oral Drug Combination for the Treatment of Mycobacterium abscessus Lung Disease.

Jickky Palmae Sarathy, Min Xie, Chui Fann Wong

|Nov 20, 2024
Durlobactam to boost the clinical utility of standard of care β-lactams against Mycobacterium abscessus lung disease.

Dereje A Negatu, Wassihun Wedajo Aragaw, Tewodros T Gebresilase

Pageof 11

Frequent Collaborators

27 joint publications

Véronique Dartois

15 joint publications

Martin Gengenbacher

5 joint publications

Gerhard Grüber

4 joint publications

Wassihun Wedajo Aragaw